2020 ASCO Virtual Direct™ Highlights

 

Avatar

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Olaparib More Effective as Mono or Combination Therapy?

By Total Health 1229 Videos FEATURING Carolyn Muller
128 views
October 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
GYN
19:19

2020 ASCO Update on Recurrent Ovarian Cancer: Does Secondary Cytored…

Total Health

C. Muller

24 views
07:40

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is …

Total Health

C. Muller

348 views
09:08

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Ol…

Total Health

C. Muller

128 views